CircASH1L inhibits ferroptosis and enhances cisplatin resistance by sponging miR-515-5p to regulate cell cycle-related CDCA7/RRM2 in ovarian cancer cells
BackgroundPlatinum chemotherapy, particularly cisplatin, has been the standard treatment for ovarian cancer. However, the development of resistance to cisplatin is a significant challenge during treatment. Circular RNAs (circRNAs) are a class of non-coding RNAs with a circular structure and have bee...
Saved in:
| Main Authors: | Lu Feng, Xinru Zou, Longyu Tang, Yijun Yuan, Tianwen He, Bin Su, Ying Tang, Jiang Wang, Kang Liu, Jun Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1563869/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CircASH1L-mediated tumor progression in triple-negative breast cancer: PI3K/AKT pathway mechanisms
by: Liu Haiyan, et al.
Published: (2025-08-01) -
CDCA genes as prognostic and therapeutic targets in Colon adenocarcinoma
by: Zongquan Zhao, et al.
Published: (2025-02-01) -
IGF2BP2‐induced circRNF20 facilitates breast cancer cell proliferation via the HuR/CDCA4 axis
by: Shu‐Tao Wu, et al.
Published: (2025-05-01) -
Mechanistic insights into CDCA gene family-mediated glioblastoma progression: implications for diagnosis, prognosis, and therapeutic targeting
by: Chang Liu
Published: (2025-03-01) -
CDCA4 promotes bladder cancer progression by JAK/STAT signaling pathway
by: Peng Wan, et al.
Published: (2025-01-01)